Life Science Research Tools Market By Technology (Pure genomics technologies, Cell biology technologies, Pure proteomics technologies, and Others) By Product (Reagents and Instruments) By End-User (Industrial & Applied, Academic & Government, Others) Regional Analysis & Forecast - 2026
- OI-118 |
- Published date: May, 2019 |
- Life Sciences & Healthcare |
- 0 Pages
Introduction
The global life sciences tools industry includes instruments, consumables, reagents, and various other services. Life science refers to a part of science that reviews organisms and microorganisms. It has an extensive range of fields, for example, cell biology, biotechnology, genetics, molecular biology, biomedicine, and biochemistry. In the future, the market will likewise be supported by the relatively easy approval processes for a wide scope of life science tools as compared to medical devices.
Market Overview
The global Life Science Research Tools market was valued at $XX Bn in 2018 and is forecast to grow at a strong XX% CAGR between 2018 and 2026, resulting in 2026 global sales of $XX Bn driven by owing to the growth of the healthcare industry and the increase of the R & D sector. However, complex technology and rising commodity prices are restraining market growth. One of the major trends for market growth is the quick pace of innovation in sequencings.
Life Science Research Tools Market by technology, Pure genomics technologies segment is driven by owing to the technological development in PCR technologies and growing occurrences of infectious diseases. In addition, qPCR technology is mainly used in several diagnostic and research applications. qPCR permits quantification and amplification of a real-time targeted DNA molecule
Life Science Research Tools Market depending on end user, the bio companies segment can be attributed to the Increasing food and environmental safety concerns, obtainability of research funding for academic institutions, growing number of criminal cases, increasing number of drug discovery and development related research studies, and growing incidence of target diseases and testing procedures associated to them are pushing the demand among end users.
Key Developments
- In February 2019, Danaher Corporation announced that it has entered into a definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences.
- In Jan 2018, Thermo Fisher Scientific and Illumina, Inc. announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing (NGS) platforms.
Segmentation
The global Life Science Research Tools market is segmented on the basis of technology type, Product Type, end-user and region.
Based on the Technology Type: Pure genomics technologies, Cell biology technologies, Pure proteomics technologies, and Others.
Based on the Product Type: Reagents and Instruments.
Based on the End User: Industrial & Applied, Academic & Government, Biopharma & Healthcare.
Based on the region: North America, Asia-Pacific, Europe, and LAMEA. Among that, North America is predictable to dominate the market in the upcoming future owing to the robust presence of pharmaceutical companies in this region. However, growing expenses on treatment of numerous conditions are anticipated to drive the market in the Asia Pacific region.
The report covers in-depth analysis of the Global Life Science Research Tools Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by End-user (Industrial & Applied, Academic & Government, Biopharma & Healthcare and Others). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Life Science Research Tools Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Scope:
- Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Life Science Research Tools Market.
- Provides a comparative analysis of key marketed products and pipeline market products.
- Provides key information on players involved in the Global Life Science Research Tools Market.
- Provides a complete overview of market segments and the regional outlook of Global Life Science Research Tools Market.
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
